Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
    • Corporate governance
    • Contact

    Press Releases

    Press Releases

    08-09-2022
    Daré Bioscience Reports Second Quarter 2022 Financial Results and Provides a Company Update
    08-02-2022
    Daré Bioscience to Host Second Quarter 2022 Financial Results and Company Update Conference Call and Webcast on August 9, 2022
    07-07-2022
    Daré Bioscience to Participate in Maxim Group Women’s Health Panel
    06-30-2022
    Daré Bioscience Announces Closing of Global License Agreement with Organon to Commercialize XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis
    06-24-2022
    Daré Bioscience Announces Partial Adjournment of Annual Meeting of Stockholders to July 14, 2022
    06-06-2022
    Daré Bioscience to Participate in the 2022 BIO International Convention
    05-16-2022
    Daré Bioscience to Participate in H.C. Wainwright Global Investment Conference
    05-12-2022
    Daré Bioscience Reports First Quarter 2022 Financial Results and Provides a Company Update
    05-11-2022
    Daré Bioscience Announces NIH Grant Award
    05-05-2022
    Daré Bioscience to Host First Quarter 2022 Financial Results and Company Update Conference Call and Webcast on May 12, 2022

    Pagination

    • Current page 1
    • Page 2
    • Next page next ›
    • Last page last »
    Displaying 1 - 10 of 19
    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2022 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top